UBQLN2 and amyotrophic lateral sclerosis: In 2011, Deng et al. first identified missense mutations in the Ubiquilin-2 (UBQLN2) gene in large ALS and ALS/FTD families, which has placed this protein as a new central actor in the physiopathology of ALS.